Please Wait
Applying Filters...

List of Prestwick3_000558 Active Pharmaceutical Ingredient (API) suppliers/manufacturers & exporters

Menu
$ API Ref.Price (USD/KG) : 112Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Bal Pharma

02 1LGM Pharma

03 1Metrochem API Private Limited

04 1Rochem International Inc

05 1Jai Radhe Sales

06 1Faran Shimi Pharmaceutical

07 1Ami Lifesciences Private Limited

08 1HRV Global Life Sciences

09 1Harika Drugs

10 1Acura Labs

11 1Amara Labs

12 1Angels Pharma India Private Limited

13 1Arudavis Labs

14 1CAD Middle East Pharmaceutical Industries LLC

15 1COSMA S.p.A

16 1Chemino Pharma

17 1Hengdian Group

18 1Hy-Gro Chemicals Pharmtek

19 1Indoco Remedies Limited

20 1Kimia Biosciences

21 1Kreative Organics

22 1Oceanic Laboratories

23 1Olon S.p.A

24 1Osmopharm

25 1Parshwanath Life Sciences

26 1Qingdao Qingmei Biotech

27 1Remedy Labs

28 1Shandong Keyuan Pharmaceutical

29 1Sudarshan Pharma

30 1Synergene Active Ingredients Pvt Ltd

31 1Zim Laboratories

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Bal Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.

Gliclazide

About the Company : Bal Pharma is a leading Indian pharmaceutical company with 30+ years of experience, specializing in prescription drugs, generic and OTC products, intravenous infusions, and bulk ac...

Bal Pharma is a leading Indian pharmaceutical company with 30+ years of experience, specializing in prescription drugs, generic and OTC products, intravenous infusions, and bulk actives. We are dedicated to enhancing patients' quality of life by offering products that are safe, effective, high-quality, and affordable. Bal Pharma's APIs and FDFs are produced at world-class manufacturing facilities. Our APIs are widely exported to Europe, the Far East, Latin America, Africa, the Middle East, and other global markets. Our FDFs are exported to semi-regulated and non-regulated markets, and we are now entering regulated markets.
BalPharma

02

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Gliclazide

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Gliclazide

About the Company :

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

04

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Gliclazide

About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...

Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quality ingredients manufactured in China. Headquartered in the Hauppauge, New York, Rochem has 16 offices spread across the globe to cater to the needs of its customers. Rochem’s operations are fully cGMP compliant and has been audited by the USFDA as well as several multinational organizations. It also trains and audits its partners to ensure all of their technologies and systems are FDA-compliant.
Rochem

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Gliclazide

About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...

Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete sourcing solutions for pharmaceutical products from India, including technical and regulatory assistance. It believes in providing its customers with high-quality products at reasonable prices. It has always endeavored to achieve global standards in the field of pharmaceuticals and has carved out a niche for itself through new methods based on current market needs. Today, it has established itself as a truly global company, with exports to almost every continent.
Jai Radhe Sales

06

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Gliclazide

About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...

Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs) and finished dosage forms. For the past three years, the company focused on extracting alkaloid opiates, controlled substances, and narcotics. The APIs are widely used by major pharmaceutical companies nationwide and exported to the Middle East. All production adheres to local GMP standards in an SOP-driven environment with modern systems and utilities, ensuring the highest quality and safety.
Faran Shimi Pharmaceutical

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Gliclazide

About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...

Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory therapeutic areas, Ami offers a wide range of APIs, intermediates, key starting materials, as well as contract bulk manufacturing services. Ami's manufacturing units in Gujarat and Karnataka feature dedicated clean rooms for APIs and adhere to international standards like EU-GMP, WHO-GMP, PMDA, and COFEPRIS. Ami serves as a reliable partner for contract development and manufacturing, offering generic APIs to global pharma companies across more than 60 countries.
AMI Lifesciences

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Gliclazide

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing and supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US and the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

09

Harika Drugs

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHarika Drugs has been providing a qualitative range of Bulk Drugs/ APIs since 1993.

Gliclazide

About the Company : Our endeavours also lie in the import, and domestic sourcing of raw materials from reliable vendors of the market. We have an excellent infrastructure with world class cGMP facilit...

Our endeavours also lie in the import, and domestic sourcing of raw materials from reliable vendors of the market. We have an excellent infrastructure with world class cGMP facilities. Our manufacturing unit is based near Hyderabad, which is equipped with the latest production equipment to produce super quality Bulk Drugs/APIs. Spread on the area of 18000 sq. m., our factory has high production capacity and as a result of which we are able to satisfy immediate and bulk requirements of our clients.
Harika Company Banner

10

Acura Labs

India
AAPS 2024
Not Confirmed
arrow

Acura Labs

India
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Acura Labs is one of the fastest-growing pharmaceutical companies backed by a solid and innovative R&D facility and a top-notch Active Pharmaceutical Ingredients (APIs) manufacturi...

Acura Labs is one of the fastest-growing pharmaceutical companies backed by a solid and innovative R&D facility and a top-notch Active Pharmaceutical Ingredients (APIs) manufacturing facility. We have a robust product portfolio of APIs spread across various therapeutic areas, capable of handling novel, complex and critical reactions. We are equipped with adaptable, versatile, and cutting-edge infrastructure tailored to fit any complex chemistry molecules and satisfy the needs of global innovators.
blank

11

Amara Labs

India
AAPS 2024
Not Confirmed
arrow

Amara Labs

India
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nationals Companies lik...

Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nationals Companies like Mylan and Cipla. We offer Active Pharmaceutical Ingredients, custom synthesis for Domestic, Intermediates for regulated markets with a key focus on new molecules. The manufacturing facility for production is equipped with an ability of producing Active Pharmaceutical Ingredients(API’s) in cGMP standards, with additional facilities of Pilot Plant with a full suite for scaling up and validation of new molecules
blank

12

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : APIPL is a fully-integrated Indian pharmaceutical company manufacturing APIs for various segments. We are one of the quality manufacturers and suppliers of over a dozen APIs. These...

APIPL is a fully-integrated Indian pharmaceutical company manufacturing APIs for various segments. We are one of the quality manufacturers and suppliers of over a dozen APIs. These are produced right from the basic stage at manufacturing facilities endorsed by the world’s most discerning drug regulatory authorities like US-FDA, UK-MHRA, EDQM-Europe, WHO and many more. We are expanding and vertically integrated for many lines to allow better control of the product lifecycle and supply chain.
blank

13

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Indus...

Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Industries all over the world for the past 10 years with good track regard of keeping our customers happy. We are specialized in the area of Vitamins, Nutraceuticals and Excipients. Our main products are N-Acetyl-L-Cysteine, Pyridoxine Hydrochloride, Thiamine Hydrochloride and Benfotiamine. The company growth is mainly driven by technology based research and development to meet customer demands.
blank

14

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : CAD Middle East Pharmaceutical Industries LLC is a state-of-art manufacturing facility using latest technologies with dedication to manufacture the highest quality of Active Pharma...

CAD Middle East Pharmaceutical Industries LLC is a state-of-art manufacturing facility using latest technologies with dedication to manufacture the highest quality of Active Pharmaceutical Ingredients (APIs) following current Good Manufacturing Practices (cGMP) standards. CAD Middle East Pharmaceutical Industries LLC established in Riyadh, Kingdom of Saudi Arabia. CAD manufacturing activities started in 2013. It is our guiding principle to introduce, through continuous research and development, consistent high quality following the latest GMP standards, low cost manufacturing of Innovative APIs for our diverse client base. We accomplish this by working in partnership with the clients/partners in understanding their current and future needs.
blank

15

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Chemino Pharma’s goal is to be a top supply partner in the pharmaceutical industry with clear focus on quality, safety and affordability. The company manufactures APIs for both h...

Chemino Pharma’s goal is to be a top supply partner in the pharmaceutical industry with clear focus on quality, safety and affordability. The company manufactures APIs for both human & veterinary use and intermediate chemicals. It has a modern facility with advanced infrastructure and a team of experts with deep industry knowledge. With the acquisition of Shakti Bioscience, Chemino Pharma has broadened its product offerings, manufacturing capabilities and entry into new markets.
blank

16

COSMA S.p.A

Italy
AAPS 2024
Not Confirmed
arrow

COSMA S.p.A

Italy
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Founded in 1977 and first inspected by FDA in 1984, COSMA SpA is the largest plant of the group and with over 130 m3 of reaction volume is focused on large-volume APIs. Brand new s...

Founded in 1977 and first inspected by FDA in 1984, COSMA SpA is the largest plant of the group and with over 130 m3 of reaction volume is focused on large-volume APIs. Brand new state-of-the-art additional production facilities have been built in 2011 and 2012. COSMA is located in Ciserano, near Bergamo, approximately 45 km from Milan.
blank

17

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : HENGDIAN GROUP was established in 1975, till now it has become a transnational,conglomerate group and been one of the largest private-owned enterprises in China. The Pharmaceutical...

HENGDIAN GROUP was established in 1975, till now it has become a transnational,conglomerate group and been one of the largest private-owned enterprises in China. The Pharmaceutical & Chemical division has 3 sub-companies with over 3,000 employees of which over 30% are technicians; This division is mainly producing APIs, Agrochemical and Dyestuffs with related intermediates as well as other special chemicals. The group also focuses on CONTRACT MANUFACTURE service under GMP and confidential agreement with our clients.
blank

18

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Hy-Gro Chemicals Pharmtek Pvt. Ltd. (Hy-Gro) is a fast growing pharmaceutical company engaged in the manufacture of Active Pharmaceutical Ingredients (APIs), Advanced Intermediates...

Hy-Gro Chemicals Pharmtek Pvt. Ltd. (Hy-Gro) is a fast growing pharmaceutical company engaged in the manufacture of Active Pharmaceutical Ingredients (APIs), Advanced Intermediates, specialized Fine Chemicals and Finished Dosages. Hy-Gro is led by a team of professional and technically proficient individuals enabling a sustainable growth trajectory for the company. We currently have 3 GMP compliant manufacturing facilities located in India. Hy-Gro was established in early 1970's as a trading company and ventured into the manufacture of bulk drugs in an associate company in 1980.
blank

19

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in India. Indoco has a strong int...

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in India. Indoco has a strong international presence in the Regulated and Emerging markets. The Company is striving to place itself on a strong promising path by expanding its business strategically, strengthening its manufacturing facilities and enhancing capabilities across the organization. The Company is looking at various opportunities in untapped markets and association with business partners in the global markets to boost its revenues.
blank

20

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kim...

Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kimia aims to become a globally recognized company in both APIs and FDFs while upholding clean business practices. Kimia's state-of-the-art facilities at Village Bhondsi, Gurugram enable it to produce a wide range of APIs. Kimia also plans to establish its own facilities for lifestyle segments, adhering to international regulatory standards. Kimia aims to provide the best pharmaceutical products and support to consumers and healthcare professionals.
blank

21

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Kreative Organics Private Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs) for the world market. Kreative started operations in 1990. Kreative was established ...

Kreative Organics Private Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs) for the world market. Kreative started operations in 1990. Kreative was established by Dr. S. Krishnamohan. Dr. Krishnamohan was formerly with TIFR, BARC, Caltech and NASA. He is a scientist of international repute and runs Kreative with professionalism and a focus on innovation. Kreative maintains strict quality standards and has developed a robust quality system around which all of our products are manufactured. Kreative invested in a state of the art cGMP facility in 2005 and expanded it to a US FDA class facility in 2013.
blank

22

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Established in 1991, our company has embarked on an impressive journey spanning over thirty years. From modest beginnings, we have evolved into a leading manufacturer of APIs, Bulk...

Established in 1991, our company has embarked on an impressive journey spanning over thirty years. From modest beginnings, we have evolved into a leading manufacturer of APIs, Bulk Drugs, and Drug Intermediates including Nutraceuticals, Pyridine/Picoline Derivatives, Anti-Coagulants, Anthelmintics, and more.Throughout our history, we have remained adaptable to shifting market trends and have embraced innovation as a fundamental aspect of our operations. With the expertise of our skilled team, we have expanded our portfolio to include additional molecules such as dietary supplements, anti-inflammatories, anti-allergics and antidiabetics.
blank

23

Olon S.p.A

Italy
AAPS 2024
Not Confirmed
arrow

Olon S.p.A

Italy
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...

We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs) in our network of facilities allows clients full access to integrated services resulting in faster production and delivery timelines, with one of the most extensive track records. We rely on synthetic and biological processes both for generic and contract development and the manufacturing market, in a full cGMPs environment, following ICH Q7 compliance.
blank

24

Osmopharm

Switzerland
AAPS 2024
Not Confirmed
arrow

Osmopharm

Switzerland
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Osmopharm S.A. is a GMP approved pharmaceutical company located in Switzerland and specialized in development and production of modified release solid oral form drugs under contrac...

Osmopharm S.A. is a GMP approved pharmaceutical company located in Switzerland and specialized in development and production of modified release solid oral form drugs under contract manufacturing.Our aim is to secure long term industrial productions for clients who register our formulation by themselves under their own brand (we are not the Marketing Authorization Holder).In order to support our clients with the registration, we can provide, under Secrecy and Supply Agreement, the technical documentation (Module 3 CTD dossier).For the time being we are not providing bioequivalence studies - those are in charge of the customers, if needed.
blank

25

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : We are working in this business since last 14 years, supplying chemicals of all Grades & Quality to our valued customers in major Industries, entirely to their satisfaction and at ...

We are working in this business since last 14 years, supplying chemicals of all Grades & Quality to our valued customers in major Industries, entirely to their satisfaction and at best possible prevailing rates. We have a very strong customer base as we are recommended by many institutions & traders by giving priority to purchase through us because of our high quality products at competitive & reasonable price.
blank

26

Remedy Labs

India
AAPS 2024
Not Confirmed
arrow

Remedy Labs

India
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Based in Ahmedabad, Gujarat, India, we are a reputed Manufacturer, Exporter and Supplier of bulk drugs, fine chemicals and intermediates. Some of our products include Triclosan, Di...

Based in Ahmedabad, Gujarat, India, we are a reputed Manufacturer, Exporter and Supplier of bulk drugs, fine chemicals and intermediates. Some of our products include Triclosan, Diclofenic Sodium, Benzocaine, Paracetamol, Sodium Monochloro Acetate, Monochloro Acetic Acid and Carbamazepine. Having rich experience and in-depth knowledge of the medical industry, we are able to hold the business with result bound solutions. We carry each assigned job work as per prevailing market trends, giving due emphasis on clients drawn specifications. All these have helped us to earn a reputed position in the marketplace.
blank

27

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Shandong Keyuan Pharmaceutical Co., Ltd. is dedicated to APIs' development, manufacturing and marketing as well as international custom manufacturing (CMO) business. Keyuan has est...

Shandong Keyuan Pharmaceutical Co., Ltd. is dedicated to APIs' development, manufacturing and marketing as well as international custom manufacturing (CMO) business. Keyuan has established strategic cooperation with internationally renowned companies.Main products: Gliclazide, Metformin Hydrochloride, Isosorbide Mononitrate, Isosorbide Dinitrate, Isoflurane, Ropivacaine Hydrochloride, Clarithromycin Laclobionate etc.Certifications: Gliclazide and Isosorbide Mononitrate
blank

28

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Sudarshan Pharma operates in the pharmaceutical and specialty chemicals industries. Their specialty chemicals and intermediates are used in pharma, paint, food, and adhesive sector...

Sudarshan Pharma operates in the pharmaceutical and specialty chemicals industries. Their specialty chemicals and intermediates are used in pharma, paint, food, and adhesive sectors. The company has a strong presence in both India and international markets, exporting products to the UK, Australia, Uzbekistan, Syria, Oman, Taiwan, and the MENA regions.
blank

29

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals...

Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals Ingredients (API'S) for wide range of therapeutic categories. Therapeutic segments of focus are Anti Fungals, Anti Depressants, and Anti Hypertensive. Synergene manufacturing facilities are cGMP compliant meeting global standards in terms of infrastructure and systems. The company has two manufacturing facilities located at Hyderabad & Vishakhapatnam manufacturing Active Pharmaceutical Ingredients and Intermediates.
blank

30

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Gliclazide

About the Company : Incepted in 1989, Zim has made a significant mark as a maverick pharma innovator. Throughout all these years constantly penetrating newer areas of pharmaceutical technology and bus...

Incepted in 1989, Zim has made a significant mark as a maverick pharma innovator. Throughout all these years constantly penetrating newer areas of pharmaceutical technology and business, Zim has established itself as one of the preferred healthcare solution provider in the field of new drug delivery systems. Headquartered in central India, in the industrial belt of Nagpur, we are a WHO GMP certified and ISO 9001:2008 accredited company supported by an excellent team of professionals and we have sufficient capacity to meet large requirements for different market segments. We are engaged in research and development, manufacturing, distribution and marketing of pharmaceutical dosage forms such as tablets, capsules, pellets, multi-particulate systems, dry syrups, directly compressible granules, taste masked powders, granules and orally disintegrating strips. At Zim we believe in constant innovation. We have earned appreciation for quality products and prompt services by domestic and international clients. Our business strategy is to innovate and deliver high-throughput technology based niche products. Zim is known in diverse, high-growth, niche markets, for institutional and pre-formulation intermediate businesses.
blank